Afatinib is an antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy.
CAT Number | CHR-9122018-4593 |
---|---|
CAS Number | 179552-74-0 |
Mol.F | C15H10ClFN4O3 |
Mol.Wt | 348.716 g/mol |
Inventory status | In-Stock |
CAT Number | CHR-9122018-4609 |
---|---|
CAS Number | 314771-88-5 |
Mol.F | C18H14ClFN4O4 |
Mol.Wt | 404.780 g/mol |
Inventory status | In-Stock |